Stockreport

Passage Bio Achieves Milestones in Gene Therapy Trials [Yahoo! Finance]

Passage Bio, Inc.  (PASG) 
PDF therapy trials for FTD-GRN, revealing promising interim data that shows potential as a leading progranulin-raising therapy. With patient enrollment on track and robust p [Read more]